A preliminary analysis of data from the first COVID-19 pneumonia patients enrolled in the ODYSSEY trial revealed that tradipitant may expedite clinical improvement.
List view / Grid view
Vanda Pharmaceuticals Inc
5 August 2015 | By Victoria White
Pivotal trial results from Phase III studies of Vanda Pharmaceuticals’ Hetlioz® (tasimelteon) have been published in The Lancet...